Author:
Kim Tae-Hyoung,Lee Jeong-Ha,Chae Yu Na,Jung Il-Hoon,Kim Mi-Kyung
Reference52 articles.
1. Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction;Achari;Int. J. Mol. Sci.,2017
2. Fixed-dose combination of alogliptin/pioglitazone improves glycemic control in Japanese patients with type 2 diabetes mellitus independent of body mass index;Aoki;Nagoya J. Med. Sci.,2017
3. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes;Basu;Diabetes,2008
4. Beneficial effects of evogliptin, a novel dipeptidyl peptidase 4 inhibitor, on adiposity with increased Ppargc1a in white adipose tissue in obese mice;Chae;PLoS One,2015
5. Hypoxia alters the expression of dipeptidyl peptidase 4 and induces developmental remodeling of human preadipocytes;Chowdhury;J. Diabetes Res.,2016
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献